6 employees
mimiX Biotherapeutics provides a point-of-care tissue engineering approach to regenerative, patient-tailored precision medicine.
2019
$10K
from 2 investors over 2 rounds
mimiX Biotherapeutics raised undisclosed on December 21, 2022
Investors: Heraeus
mimiX Biotherapeutics raised $10K on March 31, 2020
Investors: Venture Kick